EJC Supplements

Published by: Pergamon-Elsevier Science Ltd  

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Blasberg
    Blasberg
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Chandarlapaty
    Chandarlapaty
  7. Chiosis
    Chiosis
  8. Fleisher
    Fleisher
  9. Fuks
    Fuks
  10. Houghton
    Houghton

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (11)
  2. Sloan Kettering Institute Faculty (11)
  3. GSK Faculty (10)
  4. Department of Medicine (6)
  5. Genitourinary Oncology Service (6)
  6. Human Oncology and Pathogenesis Program (6)
  7. Solid Tumor Oncology Division (6)
  8. Breast Medicine Service (5)
  9. Sloan Kettering Institute Postdocs (3)
  10. Center for Hematologic Malignancies (2)
Search Within
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (11)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (11)
  2. Sloan Kettering Institute Faculty (11)
  3. GSK Faculty (10)
  4. Department of Medicine (6)
  5. Genitourinary Oncology Service (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. David Solit (5)
  2. Neal Rosen (5)
  3. Qing Ye (3)
  4. Howard Scher (2)
  5. Ronald Blasberg (2)
  6. Agnes Viale (1)

More People

Years
  1. 2008 (1)
  2. 2006 (6)
  3. 2005 (2)
  4. 2003 (2)
Publishers
  1. Pergamon-Elsevier Science Ltd (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortium
    Meeting Abstract

    Scher, H.; Beer, T.; Higano, C.; Logothetis, C.; Shelkey, J.; Hung, D.; Hirmand, M.; Larson, S.; Fleisher, M.; Sawyers, C.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Combined inhibition of PI3K/AKT and MAPK signaling is required to inhibit translational initiation and to induce apoptosis in human tumors
    Meeting Abstract

    She, Q. B.; Ye, Q.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • TGF beta pathway imaging in metastases
    Meeting Abstract

    Serganova, I.; Blasberg, R.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Inhibition of Hsp90 function downregulates EGFR and sensitizes EGFR-mutant xenografts to paclitaxel
    Meeting Abstract

    Sawai, A.; Greulich, H.; Ye, Q.; Sellers, W.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • B-RAF mutation is associated with altered patterns of negative feedback of MAPK signaling that correlate with increased output of the pathway and increased sensitivity to MEK inhibition
    Meeting Abstract

    Pratilas, C.; Grbovic, O.; Zhao, H.; Viale, A.; Solit, D.; Rosen, N.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Defining Hsp90 as inhibitor of apoptosis in small cell lung cancer
    Meeting Abstract

    Chiosis, G.; Rodina, A.; Kim, J.; Aguirre, J.; Moulick, K.; Lopes, E. C.; Wu, N.; She, Y.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Intensity modulated radiotherapy (IMRT) for prostate cancer: An update
    Meeting Abstract

    Fuks, Z.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Phase I study of HSPPC-96 (Oncophage(R)) vaccine in patients with completely resected pancreatic adenocarcinoma
    Meeting Abstract

    Maki, R. G.; Lewis, J. J.; Janetzki, S.; Klimstra, D.; Desantis, D.; Hirst, C.; Houghton, A. N.; Srivastava, P. K.; Brennan, M. F.
    EJC Supplements (2003)

    Fulltext@MSK | Save

    • EJC Supplements – authorized name for:

    Name ISSN / ISBN Publisher
    EJC Supplements 1359-6349 Pergamon-Elsevier Science Ltd
    EJC Supplements 1359-6349 Unknown
    European Journal of Cancer Supplements 1359-6349 Elsevier Inc.
    European Journal of Cancer Supplements 1359-6349 Elsevier Inc.
    European Journal of Cancer Supplements 1359-6349 Pergamon-Elsevier Science Ltd
    European Journal of Cancer, Supplement 13596349 Elsevier Inc.
    European Journal of Cancer, Supplement 13596349 Unknown